| Lang, Jinyi |
NCT02633176: Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 120 | RoW | Cetuximab, Erbitux, Cisplatin, Docetaxel, Taxotere, Capecitabine, Xeloda, Radiotherapy | Sun Yat-sen University, Chinese Southwest Oncology Group | Nasopharyngeal Carcinoma | 01/23 | | | |
Redbull-1, NCT04949503: A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN |
|
|
| Completed | N/A | 1931 | RoW | nimotuzumab, chemoradiotherapy | Biotech Pharmaceutical Co., Ltd. | Locally Advanced Head and Neck Squamous Cell Carcinoma | 03/23 | 04/23 | | |
| Li, Qiang |
NCT05689008: UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia |
|
|
| Recruiting | 3 | 60 | RoW | UC-MSCs treatment | Shanghai East Hospital, Sir Run Run Shaw Hospital | Mesenchymal Stem Cell, COVID-19 Pneumonia | 03/23 | 07/23 | | |
| Completed | 3 | 806 | Europe, Canada, US, RoW | Placebo, Mepolizumab | GlaxoSmithKline, PPD DEVELOPMENT, LP | Pulmonary Disease, Chronic Obstructive | 08/24 | 08/24 | | |
|
|
|
|
|
| Recruiting | 3 | 870 | US | Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) | Non-muscle-invasive Bladder Cancer | 11/29 | 10/30 | | |
NCT05638776: Treatment of Chronic Obstructive Pulmonary Disease (COPD) with Diffusion Capacity Defect by REGEND001 Cell Therapy |
|
|
| Active, not recruiting | 2 | 58 | RoW | REGEND001 cell therapy, Placebo | Regend Therapeutics, The First Affiliated Hospital of Guangzhou Medical University, Southwest Hospital, China, Shanghai Zhongshan Hospital, China-Japan Friendship Hospital, Shanghai East Hospital, Regend Therapeutics XLotus (Jiangxi) Co, Ltd., The First Affiliated Hospital of Nanchang University, Xiangya Hospital of Central South University, The First Affiliated Hospital of Soochow University | Chronic Obstructive Pulmonary Disease | 06/25 | 12/25 | | |
NCT04675632: Impact of Tibial Run Off on Clinical Outcome of Endovascular Therapy in Femoropopliteal Lesions (TALENT Study) |
|
|
| Recruiting | N/A | 1200 | RoW | Endovascular Therapy | Chengdu University of Traditional Chinese Medicine | Femoropopliteal Artery Occlusion | 01/23 | 01/25 | | |
PROSTA, NCT05356767: The Study of Percutaneous Mechanical Thrombectomy Treating Acute Deep Vein Thrombosis of Lower Extremities |
|
|
| Recruiting | N/A | 600 | RoW | Pharmacomechanical thrombolysis | Chengdu University of Traditional Chinese Medicine | Pharmacomechanical Thrombolysis, Deep Vein Thrombosis | 04/24 | 04/26 | | |
PROMISING, NCT04826705: A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon |
|
|
| Active, not recruiting | N/A | 2000 | RoW | Drug-coated Balloon | Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, RenJi Hospital, Zhejiang University, Xuanwu Hospital, Beijing, First People's Hospital of Hangzhou, Second Affiliated Hospital of Suzhou University, Qingdao University, Chengdu University of Traditional Chinese Medicine | Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty | 02/25 | 02/27 | | |
NCT05866029: Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture |
|
|
| Recruiting | N/A | 2478 | RoW | Denosumab, Teriparatide | Peking Union Medical College Hospital | Osteoporotic Fractures | 09/26 | 09/26 | | |
NCT04861506: The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity. |
|
|
| Recruiting | N/A | 400 | RoW | endovascular treatment | First People's Hospital of Hangzhou, RenJi Hospital, First Affiliated Hospital of Zhejiang University, Xuanwu Hospital, Beijing, Qingdao haici hospital, Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, Second Affiliated Hospital of Suzhou University, Chengdu University of Traditional Chinese Medicine, Shanghai Zhongshan Hospital | Thromboembolic Disease, Lower Extremity Problem, Endovascular Treatment, Safety Issues, Efficacy, Self | 12/23 | 12/25 | | |
EAST-CFA, NCT05603546: A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion |
|
|
| Recruiting | N/A | 300 | RoW | | Qingdao Hiser Medical Group | Common Femoral Artery Occlusive Disease | 02/24 | 02/26 | | |
| Recruiting | N/A | 1000 | RoW | drug-coated balloon | Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology, Xuanwu Hospital, Beijing, RenJi Hospital, Zhejiang University, First People's Hospital of Hangzhou, Second Affiliated Hospital of Suzhou University, Qingdao University, Chengdu University of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Huashan Hospital | Arteriosclerosis, Peripheral Artery Disease, Chronic Limb Threatening Ischemia | 11/25 | 11/26 | | |
| HAN, YONGTAO |
NCT03847857: Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030) |
|
|
| Active, not recruiting | 3 | 360 | RoW | Porcine Fibrin Sealant (PFS), Bioseal®, McKeown esophagectomy | Sun Yat-sen University | Esophageal Anastomotic Leak | 07/23 | 12/25 | | |
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 3 | 663 | RoW | Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel | Shanghai Junshi Bioscience Co., Ltd. | Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | 05/27 | 05/27 | | |
NCT05570487: RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY |
|
|
| Recruiting | N/A | 1600 | RoW | Since the data were collected retrospectively, there were no interventions | Yongtao Han | the Records of Esophageal Cancer | 12/22 | 10/23 | | |
| Yan, Jin |
NCT05923255: LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer |
|
|
| Recruiting | N/A | 568 | RoW | LISH （Laparoscopic Ileocecal-Sparing Right Hemicolectomy）, TRH（Traditional Laparoscopic Right Hemicolectomy） | Zhejiang University | Hepatic Flexure Colon Cancer, Proximal Transverse Colon Cancer | 05/26 | 05/31 | | |
| Xu, Peng |
NCT05545137: Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection |
|
|
| Completed | 3 | 299 | RoW | Pivmecillinam hydrochloride tablets, Selexid®, Fosfomycin Tromethamine Granules, Monurol® | Benova (Tianjin) Innovative medicine Research Co., Ltd. | Uncomplicated Urinary Tract Infection | 02/24 | 02/24 | | |
GZZJU-2021NB, NCT04861584: Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects |
|
|
| Recruiting | 2 | 41 | RoW | Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin, Toripalimab | Zhujiang Hospital | Urinary Bladder Cancer | 10/26 | 04/27 | | |
NCT06341400: RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients |
|
|
| Recruiting | 1/2 | 55 | RoW | DisitamabVedotinForIicction Toripalimab, radical cystectomy | Zhujiang Hospital | Bladder Cancer, Muscle-Invasive Bladder Carcinoma | 05/26 | 05/27 | | |
BTH-DREAM-PRIDE, NCT04948749: Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial |
|
|
| Recruiting | N/A | 792 | RoW | Drug Eluting Stent implantation, Maurora ® Sirolimus Eluting Stent implantation, Aggressive medical treatment, Dual antiplatelet therapy for 6 months, Risk factor management, Risk factor and life style management, Standard medical treatment, Dual antiplatelet therapy for 3 months | Beijing Tiantan Hospital | ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Stroke, Drug Eluting Stents (DES), Medical Treatment | 12/26 | 12/26 | | |
NCT05067101: Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer |
|
|
| Recruiting | N/A | 126 | RoW | Capsule Sparing Cystectomy (CSC), Conventional Radical Cystoprostatectomy (CRC) | Zhujiang Hospital | Bladder Cancer | 12/25 | 12/26 | | |
NCT04914039: Evaluation of CTA on the Assessment of Brain Death |
|
|
| Recruiting | N/A | 63 | RoW | Combination Product, NO CTA examination | Second Affiliated Hospital, School of Medicine, Zhejiang University | Brain Death | 02/22 | 02/23 | | |
